Skip to Main content Skip to Navigation
Journal articles

ATF6 alpha regulates morphological changes associated with senescence in human fibroblasts

Abstract : Cellular senescence is known as an anti-tumor barrier and is characterized by a number of determinants including cell cycle arrest, senescence associated beta-galactosidase activity and secretion of pro-inflammatory mediators. Senescent cells are also subjected to enlargement, cytoskeleton-mediated shape changes and organelle alterations. However, the underlying molecular mechanisms responsible for these last changes remain still uncharacterized. Herein, we have identified the Unfolded Protein Response (UPR) as a player controlling some morphological aspects of the senescent phenotype. We show that senescent fibroblasts exhibit ER expansion and mild UPR activation, but conserve an ER stress adaptive capacity similar to that of exponentially growing cells. By genetically invalidating the three UPR sensors in senescent fibroblasts, we demonstrated that ATF6 alpha signaling dictates senescence-associated cell shape modifications. We also show that ER expansion and increased secretion of the pro-inflammatory mediator IL6 were partly reversed by silencing ATF6a in senescent cells. Moreover, ATF6a drives the increase of senescence associated-beta-galactosidase activity. Collectively, these findings unveil a novel and central role for ATF6a in the establishment of morphological features of senescence in normal human primary fibroblasts.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01416106
Contributor : Laurent Jonchère <>
Submitted on : Wednesday, December 14, 2016 - 9:10:48 AM
Last modification on : Wednesday, September 30, 2020 - 4:28:02 PM

Links full text

Identifiers

Citation

Clementine Druelle, Claire Drullion, Julie Desle, Nathalie Martini, Laure Saas, et al.. ATF6 alpha regulates morphological changes associated with senescence in human fibroblasts. Oncotarget, Impact journals, 2016, 7 (42), pp.67699--67715. ⟨10.18632/oncotarget.11505⟩. ⟨hal-01416106⟩

Share

Metrics

Record views

363